Tag: Outbound Licensing
Cooley advises Jacobio’s USD2bn licensing deal with AstraZeneca
Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca
Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca
South Korea’s maritime hub status grows with advanced ports, shipbuilding strength, trade volumes and dispute resolution.
Trademark disputes, regulatory reforms and expansion pressures are forcing businesses to rethink brand protection
Follow us on LinkedIn